期刊
CURRENT OPINION IN PHARMACOLOGY
卷 40, 期 -, 页码 147-155出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2018.05.007
关键词
-
资金
- Dutch Cancer Society [UMCIJ-7141]
- STEM-AGING [ERC-2016-AdG-741966]
- 'Maria de Maeztu' Program for Units of Excellence in RD [MDM-2014-0370]
- [SAF2015-67369-R]
Aging is the prime risk factor for the broad-based development of diseases. Frailty is a phenotypical hallmark of aging and is often used to assess whether the predicted benefits of a therapy outweigh the risks for older patients. Senescent cells form as a consequence of unresolved molecular damage and persistently secrete molecules that can impair tissue function. Recent evidence shows senescent cells can chronically interfere with stem cell function and drive aging of the musculoskeletal system. In addition, targeted apoptosis of senescent cells can restore tissue homeostasis in aged animals. Thus, targeting cellular senescence provides new therapeutic opportunities for the intervention of frailty-associated pathologies and could have pleiotropic health benefits.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据